-
Wang WS, Chen YS, Kuo CY, Tsai JJ, Hsu FT, Chung JG, Pan PJ : DNA damage and NF-κB inactivation implicate glycyrrhizic acid-induced G1 phase arrest in hepatocellular carcinoma cells. J Food Biochem . 2022 Jul;46(7):e14128.
-
Wu CH, Lin KH, Fu BS, Hsu FT, Tsai JJ, Weng MC, Pan PJ. Sorafenib Induces Apoptosis and Inhibits NF-κB-mediated Anti-apoptotic and Metastatic Potential in Osteosarcoma Cells. Anticancer Res. 2021 Mar;41(3):1251-1259.
-
Liu YC, Tsai JJ*, Weng YS, Hsu FT. Regorafenib suppresses epidermal growth factor receptor signaling-modulated progression of colorectal cancer. Biomed Pharmacother. 2020 Aug;128:110319. (共同第一作者)
-
Tsai JJ, Hsu FT, Pan PJ, Chung JG, I-Tsang Chiang. Glycyrrhizic acid modulates apoptosis through extrinsic/intrinsic pathways and inhibits AKT and ERK-mediated metastatic potential in hepatocellular carcinoma in vitro and in vivo. The American Journal of Chinese Medicine 2020;48(1):223-244.
-
Tsai JJ, Chen JH, Chen CH, Chung JG, Hsu FT. Apoptosis induction and suppression of ERK/NF-B activation are associated with magnolol-inhibited tumor progression in hepatocellular carcinoma in vivo. Environ Toxicol. 2020 Feb;35(2):167-175.
-
Tsai JJ, Chen JH, Chen CH, Chung JG, Hsu FT (2019): Apoptosis induction and suppression of ERK/NF-κB activation are associated with magnolol-inhibited tumor progression in hepatocellular carcinoma in vivo. Environmental toxicology 35(2):167-175. (*cocorresponding author)
-
Weng MC, Wang MH, Tsai JJ, Kuo YC, Liu YC, Hsu FT, Wang HE. Regorafenib inhibits tumor progression through suppression of ERK/NF-κB activation in hepatocellular carcinoma bearing mice. Biosci Rep. 2018 Jun 29; 38(3):
-
Tsai JJ, Hsu FT, Pan PJ, Chen CW, Kuo YC. Amentoflavone Enhances the Therapeutic Efficacy of Sorafenib by Inhibiting Anti-apoptotic Potential and Potentiating Apoptosis in Hepatocellular Carcinoma In Vivo. Anticancer Res. 2018 Apr;38(4):2119-2125.